Revised: 2 October 2014

Committees

Comments on Agenda Items for the 52nd Medicines Classification Committee meeting

A total of 14 comments on agenda items for the 52nd meeting were received. (PDF Document 3254KB - 73 pages)

One comment was received regarding the reclassification of rizatriptan from prescription to restricted medicine following a recommendation at the 43rd meeting (agenda item 5.2).

Seven comments were received regarding the proposed reclassification of beclomethasone from pharmacy-only medicine to general sale medicine (agenda item 6.1).

Eight comments were received regarding the proposed reclassification of omeprazole - proposed reclassification from pharmacy-only medicine to general sale medicine (agenda item 6.2).

Nine comments were received regarding the proposed reclassification of paracetamol in combination with phenylephrine (agenda item 6.3).

Three comments have not been published.